Genus annual book value per share
2022
2023
2024
2025
2026
Genus Book Value Per Share Growth & History (GNS)
Genus's book value per share was £11.60 for fiscal 2026.
View full Genus company overviewGenus annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | £11.60 | £4.35 | +60.03% |
| 2025 | 2025-06-30 | £7.25 | -£0.63 | −8.05% |
| 2024 | 2024-06-30 | £7.88 | -£0.42 | −5.09% |
| 2023 | 2023-06-30 | £8.31 | -£0.54 | −6.10% |
| 2022 | 2022-06-30 | £8.85 | — | — |
Genus quarterly book value per share
Q2.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-12-31 | £7.59 | -£0.27 | −3.41% |
| Q4 2025 | 2025-06-30 | £7.24 | — | — |
| Q2 2025 | 2024-12-31 | £7.86 | — | — |
Genus book value per share trends
Between the periods ended 2022-06-30 and 2026-06-30, Genus's book value per share increased from £8.85 to £11.60, a change of £2.75. The latest reported quarter, Q2 2026, shows £7.59.
About the metric
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
Calculation and source
How book value per share is calculated
TickerStat calculates book value per share as reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genus source filings ↗Community posts
Genus announces a £60 million buyback after stronger annual earnings
Genus ($GNS-LSE) announced a £60 million share-buyback program after adjusted pre-tax profit rose 35% to £100.2 million. Revenue declined 2% to £658.1 million, but stronger profitability in its pig-genetics business and improvements in its ...
